TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE | N207981 | TAIHO ONCOLOGY INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Taiho Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al 1 patentANDA 214024trifluridine and tipiracil (α,α,α-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride) | D. Del. | 2023-01-03 | Active | — |
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities, Ltd. et al 2 patentsANDA 213893trifluridine and tipiracil | D. Del. | 2022-12-20 | Terminated 2024-04-03 | — |
Taiho Pharmaceutical Co., Ltd. et al v. MSN Laboratories Private Ltd. et al 1 patentANDA 214036trifluridine and tipiracil | D. Del. | 2021-06-09 | Active | — |
Taiho Pharmaceutical Co., Ltd. et al v. Natco Pharma Ltd. et al 3 patentsANDA 214008trifluridine and tipiracil | D. Del. | 2019-12-30 | Terminated 2024-04-11 | — |
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al 2 patentsANDA 213893trifluridine and tipiracil | D. Del. | 2019-12-19 | Terminated 2024-04-03 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).